InvestorsHub Logo
Followers 59
Posts 11472
Boards Moderated 0
Alias Born 07/16/2006

Re: floblu14 post# 13193

Monday, 03/16/2015 5:26:06 PM

Monday, March 16, 2015 5:26:06 PM

Post# of 20689
If I had a nickel for every drug that looked good in preclinical only to bomb out later I'd be able to buy Momenta.

I'm pretty sure your sif's dropped by a factor of 50 in animal models. Still positive.

"The preclinical data from these studies indicate that hsIVIg can provide consistent, enhanced anti-inflammatory activity up to ten-fold higher than IVIg in animal models of diseases such as arthritis, immune thrombocytopenia (ITP) and skin blistering diseases.